logo
Our Place founder warns supermarket dupes will 'cause businesses to fail'

Our Place founder warns supermarket dupes will 'cause businesses to fail'

Yahoo18 hours ago
Supermarkets launching copycat versions of labels will 'destroy' innovation and cause small businesses to fail, the co-founder of a kitchenware brand backed by Gwyneth Paltrow and Jay-Z has warned.
Our Place co-founder and co-chief executive Shiza Shahid said the brand was growing rapidly in the UK despite dupes appearing on the market.
Ms Shahid launched the Los Angeles-based business with her husband in 2019, with Will Smith's Dreamers VC, Jay-Z's Marcy Venture Partners, and Gwyneth Paltrow among its early investors.
It specialises in kitchenware including pans designed to be non-toxic and non-stick, and collections created in complementary colours and aesthetics.
Widely-shared posts on social media, especially Instagram, have helped drive popularity of the brand in recent years – including a collaboration with actress and singer Selena Gomez.
Similar versions of bestselling products – namely the 'Always Pan' which currently sells for £125 – have recently launched in supermarkets including Aldi and Marks & Spencer with a lower price tag.
Ms Shahid told the PA news agency: 'Unfortunately I think it is incredibly harmful.
'When we started Our Place, my partner and I bootstrapped our savings and worked on the design for two years before we ever sold a single unit.
'And when multi-million dollar corporations come and they knock it off, with no regard for innovation, IP, small business, they are causing tremendous harm and it will cause a lot of businesses to fail, and it will destroy innovation.'
She said such companies are 'very skilled in the art of duplicity' which makes it difficult and costly for smaller brands to legally challenge.
But the businesswoman told PA that they were 'not able to guarantee that same level of detail and quality' with replica products.
'So we trust that, while not every consumer will see the difference, many will and many do,' she said, adding that shoppers often want to 'support brands that they believe in'.
A spokesman for Aldi said: 'For over 35 years we have championed customers by offering high quality exclusive products at the lowest possible prices.
'We go to great lengths to ensure that all our exclusive brand products are compliant with strict copyright laws and regulations.'
M&S has been contacted for comment.
Ms Shahid, who also co-founded the Malala Fund with Nobel Prize winner and campaigner Malala Yousafzai, said Our Place products are typically viewed as an 'accessible luxury'.
'Despite some of the cost-of-living challenges, people are investing in the home and kitchen,' she told PA.
'The first thing you do is maybe you go out a little bit less, but then you still want the joy and the nourishment and the connection, and home cooking is a really great way to do that.
'It feels like an everyday luxury… people are choosing products that will last, that will bring joy, and that will actually help them save money over time.'
Sales across the brand spiked by 92% over the first quarter of 2025 compared with the same period last year, and it has built more than a million active customers.
It is also set to launch a shop-in-shop space within London department store Selfridges amid efforts to expand into retailers and take on established competitors such as Le Creuset.
Ms Shahid said Our Place has 'a lot of younger consumers but we also have a lot of men and women in their 60s', while many of its products – including the countertop 'wonder oven' – appeal to single-person households and small families.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Blackstone Explores Potential Joint Bid for Drahi's SFR
Blackstone Explores Potential Joint Bid for Drahi's SFR

Bloomberg

time17 minutes ago

  • Bloomberg

Blackstone Explores Potential Joint Bid for Drahi's SFR

Blackstone Inc. is studying a potential joint bid for billionaire Patrick Drahi's French telecom operator SFR, which is considering a sale at a valuation of as much as €30 billion ($35 billion) including debt, according to people familiar with the matter. The New York-based firm has been in early discussions with other potential suitors including SFR competitors as it evaluates the merits of a deal, the people said. Blackstone is likely to team up with another bidder given the operational needs of the Altice France SA -owned carrier, said the people, who asked not to be identified as the information is private.

Stellantis dips as BofA downgrades stock on Europe concerns, fears of weak results
Stellantis dips as BofA downgrades stock on Europe concerns, fears of weak results

Yahoo

time19 minutes ago

  • Yahoo

Stellantis dips as BofA downgrades stock on Europe concerns, fears of weak results

-- Stellantis' U.S. shares dipped nearly 5% in premarket trading Monday after Bank of America (BofA) downgraded the stock to Neutral from Buy, citing concerns about its European business and weak upcoming results. The price objective was also slashed from €16 to €10, as the bank warned it is 'too early for 'bottom-fishing'' despite the sharp decline in the share price this year. BofA expects a difficult first half (H1) for Stellantis (NYSE:STLA), projecting a 15% year-on-year drop in revenues and a group adjusted EBIT margin of just 2.7%. 'We think consensus estimates will continue to come down after H1 results,' the analysts Horst Schneider and Alexander Jones said, adding they fear both H1 and H2 numbers will disappoint. Stellantis (NYSE:STLA) is set to report its H1 results on July 29, 2025. The note flags structural issues in Europe, where Stellantis is seen as poorly positioned in battery electric vehicles (BEV). Analysts estimate the company must lift its BEV share in Europe from under 10% in 2024 to more than 45% by 2030 to meet regulations, but face cost disadvantages from its multi-energy platform strategy. Stellantis' market share in Europe has stabilized, but the product mix remains unfavorable, analysts note, with declining sales of profitable light commercial vehicles (LCVs) and rising BEV volumes. With the company still de-stocking, BofA expects trade payables to be low in Q2 and forecasts an industrial cash burn of about €2.5 billion for the first half of 2025, more than double consensus expectations. Elsewhere, the bank sees potential for earnings recovery in North America, led by new model launches at Jeep and RAM, but it notes the turnaround will take time and remains cautious. BofA sees the full-year 2025 (FY25) as 'a year of transition.' For 2025, its adjusted EBIT estimate is about 35% below consensus, and 10% below for 2026. The Wall Street firm also flagged foreign exchange headwinds from a weaker U.S. dollar and warned that restructuring costs could rise as Stellantis addresses underutilized capacity. On a more positive note, the group expects limited downside for Stellantis shares, expecting a significant earnings recovery in 2026 (FY26), driven by 13% revenue growth in North America. This rebound is tied to new model launches at Jeep and RAM, though tariff impacts remain a key uncertainty. Longer-term, a full model overhaul in 2029 and potential strategic moves—such as brand restructuring or even a group split—could support valuation, with new 2030 targets likely to be presented at a capital markets day in late 2025 or early 2026.

Amotio secures £810k to advance orthopaedic revision surgery
Amotio secures £810k to advance orthopaedic revision surgery

Yahoo

time25 minutes ago

  • Yahoo

Amotio secures £810k to advance orthopaedic revision surgery

Welsh startup Amotio has raised £810,000 ($1.1m) to advance its technology for improving outcomes during orthopaedic revision surgery. The company's first major pre-seed funding round was led by a £500,000 ($682,000) investment from the Development Bank of Wales, with additional backing from European investment firm NLC Health Ventures and Orthopaedic Research UK. Implant fixation takes the approach of uncemented fixation, where an implant is anchored to the bone, or cemented, where an implant is fixed using a compound made of Polymethyl Methacrylate (PMMA). However, research from the UK indicates that around 7% of hip, knee, and shoulder implants require replacement due to issues such as implant failure, infection, loosening, or bone fractures. Amotio worked with biomechanical engineers from University Medical Center Utrecht to develop a solution for removing bone cement during hip revision surgery. The technology uses advanced digital joint mapping, 3D printing, and precision tools. Starting with a patient's CT scan, the system allows surgeons to collaborate with Amotio to create the surgical plan, including a custom-made guide and a specialised device for safe bone cement removal. Through early-stage investment and non-dilutive funding, Amotio has now raised around £1.6m ($2.1m), which will support the company's ongoing R&D and eventually help it progress to pre-clinical testing and regulatory approval for the technology. Amotio's eventual expectation is to expand its technology for use in all major joint surgeries for patients in global markets including the US, Europe, and the Asia-Pacific. Amotio CEO Iestyn Foster commented: 'In current financial conditions it is extremely difficult as a medtech start-up to attract initial early stage investment, but with the support of our co-founder and investor NLC Health Ventures, specialist venture funds from ORUK, and the Development Bank of Wales, they have all understood the complex needs of our business and the impact our solution will make, along with our ambitions for future growth.' In the US, major joint replacement surgeries among those aged 50 and above are projected to reach five million by 2030. "Amotio secures £810k to advance orthopaedic revision surgery" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store